{Reference Type}: Journal Article
{Title}: In-bore MRI targeted biopsy. Lights and shadows.
{Author}: Totaro A;Ragonese M;Cretì A;
{Journal}: Urologia
{Volume}: 91
{Issue}: 3
{Year}: 2024 Aug 23
暂无{DOI}: 10.1177/03915603241252912
{Abstract}: Multiparametric Magnetic Resonance Imaging (MpMRI) and MRI-guided biopsy (MRGB) are the diagnostic gold standard in the management of men with suspicious prostate cancer (PCa). There are not enough studies, yet, that compare TRUS-MRGB, COG-TB and IB-MRGB. Despite IB-MRGB could be more accurate in detecting PCa in smaller lesions and a less operator dependent technique, there are still some concerns regarding high resource costs and the chance of missing lesions not visible at MRI or detected by systematic biopsy.